David R Freyer

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. pmc Transition of care for young adult survivors of childhood and adolescent cancer: rationale and approaches
    David R Freyer
    LIFE Survivorship and Transition Program, Childrens Center for Cancer and Blood Diseases, Childrens Hospital Los Angeles, and Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    J Clin Oncol 28:4810-8. 2010
  2. doi request reprint Children's Oncology Group's 2013 blueprint for research: adolescent and young adult oncology
    David R Freyer
    Children s Center for Cancer and Blood Diseases, Children s Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA 90027 6016, USA
    Pediatr Blood Cancer 60:1055-8. 2013
  3. pmc Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group
    David R Freyer
    Children s Center for Cancer and Blood Diseases, Children s Hospital Los Angeles, CA, USA
    Blood 117:3010-5. 2011
  4. ncbi request reprint Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California
    Pediatr Blood Cancer 61:1277-81. 2014
  5. pmc Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group
    Etan Orgel
    Etan Orgel, Jonathan Jaques Children s Cancer Center, Miller Children s Hospital, Long Beach Etan Orgel, Paul S Gaynon, and David R Freyer, Keck School of Medicine, University of Southern California Etan Orgel, Richard Sposto, Jemily Malvar, Paul S Gaynon, and David R Freyer, Children s Center for Cancer and Blood Diseases, Children s Hospital Los Angeles Richard Sposto, University of Southern California, Los Angeles, CA Nita L Seibel, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD and Elena Ladas, Center for Comprehensive Wellness, Columbia University, New York, NY
    J Clin Oncol 32:1331-7. 2014
  6. doi request reprint Association of projected transfusional iron burden with treatment intensity in childhood cancer survivors
    Kathleen S Ruccione
    LIFE Cancer Survivorship and Transition Program, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
    Pediatr Blood Cancer 59:697-702. 2012
  7. doi request reprint Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California, USA
    Int J Radiat Oncol Biol Phys 86:942-8. 2013
  8. doi request reprint Exercise recommendations for childhood cancer survivors exposed to cardiotoxic therapies: an institutional clinical practice initiative
    Maki Okada
    Children s Hospital Los Angeles, CA 90027, USA
    J Pediatr Oncol Nurs 29:246-52. 2012
  9. doi request reprint Hearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach
    Etan Orgel
    Children s Center for Cancer and Blood Diseases, Children s Hospital, Los Angeles, CA, USA
    Pediatr Blood Cancer 58:953-8. 2012
  10. pmc Carnitine and cardiac dysfunction in childhood cancer survivors treated with anthracyclines
    Saro H Armenian
    Authors Affiliations Division of Outcomes Research, Department of Population Sciences, Department of Cardiology, City of Hope, Duarte Divisions of Hematology, Oncology, and Blood and Marrow Transplantation and Cardiology, Children s Hospital Los Angeles Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California and Division of Pediatric Cardiology, Department of Pediatrics and Communicable Diseases, C S Mott Children s Hospital, University of Michigan, Ann Arbor, Michigan
    Cancer Epidemiol Biomarkers Prev 23:1109-14. 2014

Detail Information

Publications10

  1. pmc Transition of care for young adult survivors of childhood and adolescent cancer: rationale and approaches
    David R Freyer
    LIFE Survivorship and Transition Program, Childrens Center for Cancer and Blood Diseases, Childrens Hospital Los Angeles, and Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    J Clin Oncol 28:4810-8. 2010
    ....
  2. doi request reprint Children's Oncology Group's 2013 blueprint for research: adolescent and young adult oncology
    David R Freyer
    Children s Center for Cancer and Blood Diseases, Children s Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA 90027 6016, USA
    Pediatr Blood Cancer 60:1055-8. 2013
    ..This experience will be useful in leveraging the new United States National Cancer Institute Clinical Trials Network to transform AYA Oncology research...
  3. pmc Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group
    David R Freyer
    Children s Center for Cancer and Blood Diseases, Children s Hospital Los Angeles, CA, USA
    Blood 117:3010-5. 2011
    ..This study is registered at www.clinicaltrials.gov as NCT00002812...
  4. ncbi request reprint Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California
    Pediatr Blood Cancer 61:1277-81. 2014
    ..The purpose of this study is to describe the prevalence of pulmonary complications in HL patients treated using contemporary protocols...
  5. pmc Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group
    Etan Orgel
    Etan Orgel, Jonathan Jaques Children s Cancer Center, Miller Children s Hospital, Long Beach Etan Orgel, Paul S Gaynon, and David R Freyer, Keck School of Medicine, University of Southern California Etan Orgel, Richard Sposto, Jemily Malvar, Paul S Gaynon, and David R Freyer, Children s Center for Cancer and Blood Diseases, Children s Hospital Los Angeles Richard Sposto, University of Southern California, Los Angeles, CA Nita L Seibel, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD and Elena Ladas, Center for Comprehensive Wellness, Columbia University, New York, NY
    J Clin Oncol 32:1331-7. 2014
    ..Inasmuch as weight varies substantially over treatment, we hypothesized its impact on EFS is instead determined by cumulative time spent at an extreme weight during therapy and on TRT by weight at the time of toxicity...
  6. doi request reprint Association of projected transfusional iron burden with treatment intensity in childhood cancer survivors
    Kathleen S Ruccione
    LIFE Cancer Survivorship and Transition Program, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
    Pediatr Blood Cancer 59:697-702. 2012
    ..The purpose of this study was to determine whether treatment intensity is predictive of projected iron burden resulting from PRBC transfusions among survivors of several forms of childhood cancer...
  7. doi request reprint Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California, USA
    Int J Radiat Oncol Biol Phys 86:942-8. 2013
    ..To identify the incidence and the risk factors for pulmonary toxicity in children treated for cancer with contemporary lung irradiation...
  8. doi request reprint Exercise recommendations for childhood cancer survivors exposed to cardiotoxic therapies: an institutional clinical practice initiative
    Maki Okada
    Children s Hospital Los Angeles, CA 90027, USA
    J Pediatr Oncol Nurs 29:246-52. 2012
    ....
  9. doi request reprint Hearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach
    Etan Orgel
    Children s Center for Cancer and Blood Diseases, Children s Hospital, Los Angeles, CA, USA
    Pediatr Blood Cancer 58:953-8. 2012
    ..The purpose of this study was to determine the prevalence and severity of ototoxicity associated with Head Start and similar irradiation-sparing regimens...
  10. pmc Carnitine and cardiac dysfunction in childhood cancer survivors treated with anthracyclines
    Saro H Armenian
    Authors Affiliations Division of Outcomes Research, Department of Population Sciences, Department of Cardiology, City of Hope, Duarte Divisions of Hematology, Oncology, and Blood and Marrow Transplantation and Cardiology, Children s Hospital Los Angeles Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California and Division of Pediatric Cardiology, Department of Pediatrics and Communicable Diseases, C S Mott Children s Hospital, University of Michigan, Ann Arbor, Michigan
    Cancer Epidemiol Biomarkers Prev 23:1109-14. 2014
    ..Cancer Epidemiol Biomarkers Prev; 23(6); 1109-14. ©2014 AACR. ..